BERWYN, PA — Amring Pharmaceuticals Inc. has announced a corporate name change to Nordic Pharma, Inc., marking a new chapter in its global growth strategy. The rebranding, effective from March 4, 2024, follows the company’s change of ownership from SEVER Life Sciences B.V. to Nordic Group B.V. on June 1, 2023. Nordic Group is a subsidiary of SEVER Life Sciences.
The name change aligns the U.S. firm more closely with its Netherlands-based parent company and its international subsidiaries. The strategic move positions Nordic Pharma for further expansion in areas such as Eye Care, Rheumatology, Women’s Health, and Critical Care. It also bolsters its efforts in strengthening the generic product business within the U.S. market.
As part of its growth strategy, Nordic Pharma recently acquired Visant Medical, Inc., a leading innovator in medical technology for Dry Eye Disease (DED). The acquisition included the FDA-cleared LACRIFILL® canalicular gel, a hyaluronic acid derivative designed to temporarily block tear drainage. Nordic Pharma plans to launch LACRIFILL in the U.S. in Q2 2024, followed by a global rollout.
Charlotte Phelps, CEO of Nordic Pharma, highlighted the merger and acquisition as a cornerstone of the company’s global expansion plans. She pointed to a range of ophthalmology products currently in phase II development, stating that combining these with existing assets and leveraging U.S. leadership expertise in ophthalmics will drive success.
Philip Gioia, President of Nordic Pharma U.S., expressed enthusiasm about leading the company during this dynamic stage. He emphasized the company’s commitment to providing quality generics in the U.S. while building an innovative proprietary ophthalmic business. He added that new ophthalmic innovations are nearing readiness for commercialization, presenting an opportune moment for Nordic Pharma to compete effectively as a specialty ophthalmic player in the U.S. and globally.
Nordic Group B.V., the parent company of Nordic Pharma, is a privately owned international pharmaceutical firm. It has built a solid foundation in Eye Care, Rheumatology, and Women’s Health through targeted developments and acquisitions. The group has established deep roots throughout Europe and has recently expanded outside of Europe with increased acquisitions worldwide.
Nordic Pharma, Inc., now under the umbrella of Nordic Group B.V., partners with well-established global biopharmaceutical companies. It is uniquely positioned to leverage its expertise in bringing biotechnology-derived medicines, sterile manufacturing, and other state-of-the-art technologies to the marketplace.
For the latest news on everything happening in Chester County and the surrounding area, be sure to follow MyChesCo on Google News and MSN.